ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases
Authors
Keywords
Bone density, Hematology, Prognosis, Ascites, Hemoglobin, Splenomegaly, Systemic mastocytosis, Monocytes
Journal
PLoS One
Volume 9, Issue 1, Pages e85362
Publisher
Public Library of Science (PLoS)
Online
2014-01-22
DOI
10.1371/journal.pone.0085362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells
- (2012) E. Soucie et al. BLOOD
- Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
- (2012) Véronique Gelsi-Boyer et al. Journal of Hematology & Oncology
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
- (2012) Jay P. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis
- (2012) Fabiola Traina et al. PLoS One
- Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
- (2011) Felicitas Thol et al. JOURNAL OF CLINICAL ONCOLOGY
- TET2Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2011) Klaus H. Metzeler et al. JOURNAL OF CLINICAL ONCOLOGY
- An evaluation of penalised survival methods for developing prognostic models with rare events
- (2011) G. Ambler et al. STATISTICS IN MEDICINE
- Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies
- (2009) A. Pardanani et al. BLOOD
- Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia
- (2009) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Variable presence ofKITD816Vin clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD)
- (2009) Karl Sotlar et al. JOURNAL OF PATHOLOGY
- Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates
- (2009) A Tefferi et al. LEUKEMIA
- TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
- (2009) A Tefferi et al. LEUKEMIA
- Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
- (2009) A Tefferi et al. LEUKEMIA
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis
- (2008) Olivier Hermine et al. PLoS One
- Phenotypic and Genotypic Characteristics of Mastocytosis According to the Age of Onset
- (2008) Fanny Lanternier et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now